Synchronous double primary cancers of adenocarcinoma of the rectum and hepatocellular carcinoma
Keywords:
double cancers , rectal carcinoma, liver carcinomaAbstract
Synchronous double primary cancers of the rectum and another have been hardly reported worldwide, so far. So, we additionally presented one patient who concurrently developed synchronous double cancers of the rectum and the hepatocellular carcinoma. He was a 65-year-old Thai who presented with hematochezia for a few days without fever or weight loss. His physical examination did not reveal any significant abnormality. The coloscopy found a rectal mass and multiple colonic polyps. The computerized tomography of the whole abdomen confirmed the rectal mass and also another mass in the liver with mild cirrhosis. His blood tests showed Hct 37.7%, elevated carcinoembryonic antigen (CEA), 22.04 ng/ml and normal alpha-fetoprotein (AFP) level, positive hepatitis B virus antigen, albumin 3.1 g%, globulin 3.6 g%. He underwent low anterior resection of the rectal mass, multiple colonic polypectomy, segmentectomy of the liver mass and colostomy and was further treated with radiation and adjuvant chemotherapy consisting of 5-fluoro uracil and leucovorin. The pathology of the rectal mass was adenocarcinoma whereas the liver mass was hepatocellular carcinoma. Nine months after treatment, the serum level of CEA appeared normal and the CT of the abdomen showed no recurrence of the liver or bowel wall carcinoma. He could still survive up to three years when this report was written. Although the primary colorectal cancer with liver metastasis is much more common than the synchronous double primary cancers of the colorectum and the liver, the liver mass biopsy must not be ignored even though the serum AFP level is not elevated, otherwise the double cancers can be overlooked and the appropriate management of the liver carcinoma will have never been accessed. The association between both cancers will be further discussed in detail.
References
Maida M, Macaluso FS, Galia M, Cabibbo G. Hepatocellular carcinoma and synchronous liver metastases from colorectal cancer in cirrhosis. World J Hepatol 2013; 5: 696-70.
Karass M, Grossniklaus E, Seoud T, Kamel R, Teniola O, Oprea G, et al. Metastatic colorectal cancer in a cirrhotic liver with synchronous hepatocellular carcinoma. Ann Transl Med 2015; 3: 321. doi: 10.3978/j.issn.2305-5839.2015.11.28.
Maruyama C, Tamaoka Y, Matsuno H, Konishi F. A case of Borrmann type 4 colon cancer with a metastasis into hepatoma Gan No Rinsho 1990; 36: 1047-52.
Siu DC, Lam CM, Yuen ST, Fan ST. Carcinoma of the colon with synchronous hepatic metastasis in a cirrhotic liver harboring a hepatocellular carcinoma. Hepatogastroenterol 1999; 46: 2355-7.
Song JW, Chun HS, Lee JS, Lee HW, Kim BK, Park JY, et al. A case of lymphocyte-rich hepatocellular carcinoma in a patient who was treated for colon cancer. J Liver Cancer 2021; 21: 69-75.
Engtrand J, Nilsson H, Stromberg C, Jonas E, Freedman J. Colorectal cancer liver metastases – a population-based study on incidence, management and survival. BMC Cancer 2018; 18: 78. https://doi.org/10.1186/s12885-017-3925-x
Holch JW, Demmer M, Lamersdorf C, Michl M, Schulz C, Von Einem JC, et al. Pattern and dynamics of distant metastases in metastatic colorectal cancer. Visc Med 2017; 33; 70-5.
Uchibori K, Kasamatsu A, Sunaga M, Yokota S, Sakurada T, Kobayashi E, et al: Establishment and characterization of two 5-fluorouracil-resistant hepatocellular carcinoma cell lines. Int J Oncol 2012; 40: 1005-10.
Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vvmetalkova V, et al. 5-Fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharmacol Therap 2020; 206: doi: 10.1016/j.pharmthera.2019.107447.
Chonprasertsuk S, Vilaichone R. Epidemiology and treatment of hepatocellular carcinoma in Thailand. Jpn J Clin Oncol 2017; 47: 294-7.
Lohsiriwat V, Chaisomboon N, Pattana-Arun J. Current colorectal cancer in Thailand. Ann Coloproctol 2020; 36: 78-82.
Chitapanarux T, Phornphutkul K. Risk factors for the development of hepatocellular carcinoma in Thailand. J Clin Transl Hepatol 2015; 3: 182-8.
Lee CW, Tsai H, Lee WC, Huang SW, Lin CY, Hsieh YC, et al. Normal alpha-fetoprotein hepatocellular carcinoma: are they really normal? J Clin Med 2019; 8: 1736. doi: 10.3390/jcm8101736
Gaillard F, Baba Y, Knipe H, et al. Hepatic metastases. Reference article, Radiopaedia.org (Accessed on 01 Nov 2023) https://doi.org/10.53347/rID-6931
Szklaruk J, Silverman PM, Charnsangavej C. Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma. Am J Roentgenol 2003; 180: 441-54. https://doi.org/10.2214/ajr.180.2.1800441.
Liu W, Wang K, Bao Q, Sun Y, Xing BC. Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma. World J Surg Oncol 2016; 14: 62. https://doi.org/10.1186/s12957-016-0811-y.
Lee WC. Value of alpha-fetoprotein in hepatocellular carcinoma. Transl Gastroenterol He patol 2021; 6: 52. Doi: 10.21037.tgh.2019.12.19.
Choi SI, Cho Y, Ki M, Kim BH, Lee IJ, Kim TH, et al. Better survival of patients with hepatitis virus B-related hepatocellular carcinoma in South Korea: Changes in 16-year cohorts. PLoS ONE 17(3): e0265668. https://doi.org/10.1371/journal.pone.0265668
Wang CB, Shahjehan F, Merchea A, Li Z, Bekaii-Saab TS, Grothey A, et al. Impact of tumor location and variables associated with overall survival in patients with colorectal cancer: A Mayo clinic colon registry study. Front Oncol 2019; 9: 76. https://doi.org/10.3389/fonc.2019.00076
Lotfollahzadeh S, Kashyap S, Tsoris A, Recio-Boiles A, Babiker HM. Rectal Cancer. [Updated 2023 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493202/
Kim HR, Joo JI, Lim SW, Oh BY. Prognostic value of carcinoembryonic antigen levels before and after curative surgery in colon cancer patients. Ann Surg Treat Res 2021; 100: 33-9.
Uchiyama H, Harimoto N, Itoh S, Yoshizumi T, Ikegami T, Maehara Y. Pleural effusion after hepatectomy for hepatocellular carcinoma: risk factor analyses and its impact on oncological outcomes. World J Surg 2017; 41: 1089-99.
Dubus T, Ari A, Koyuncu A, Tarta C. Evaluation of pleural effusions developed after abdominal operations. Med Sci 2022; 11: 537-9.
Kuo CC, Chen CY, Chen CH. Hepatocellular carcinoma with pleural metastases without residual liver tumor diagnosed by pleuroscopy. Arch Bronconeumol 2021; 57: 370.
Novakov I. Metastatic colorectal cancer presenting with malignant pleural effusion – a self - experience study. Scripta Scientifica Medica 2017; 49: 35-9.
Nitta H, Mitsuura C, Shiraishi Y, Miyata T, Shimizu K, Harada K, et al. Predictive model for postoperative pleural effusion after hepatectomy. Ann Gastroenterol Surg 2012; 5: 373-80.
Jia W, Rajani C, Xu H, Zheng X. Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma. Protein Cell 2021; 12: 374-93.
Gao T, Li M, Wu D, Xiao N, Huang D, Deng L, et al. Exploring the pathogenesis of colorectal carcinoma complicated with hepatocellular carcinoma via microarray data analysis. Front Pharmacol 2023; 14: 1201401. doi: 10.3389/fphar.2023.1201401.
Rizzo GEM, Cabibbo G, Craxi A. Hepatitis B virus-associated hepatocellular carcinoma. Viruses 2022; 14: 986. doi: 10.3390/v14050986.
Shussman N, Wexner SD. Colorectal polyps and polyposis syndrome. Gastroenterol Rep 2014; 2: 1-15.
Weinberger JM, Cohen Z, Berk T. Polyposis coli preceded by hepatocellular carcinoma: report of a case. Dis Colon Rectum 1981; 24: 296-300.
Li M, Gerber DA, Koruda M, O'Neil BH. Hepatocellular carcinoma associated with attenuated familial adenomatous polyposis: a case report and review of the literature. Clin Colorectal Cancer 2012; 11: 77-81.
Su FH, Le TN, Muo CH, Te SA, Sung FC, Yeh CC. Chronic hepatitis B virus infection associated with increased colorectal cancer risk in Taiwanese population. Viruses 2020; 12: 97. https://doi.org/10.3390/v12010097.
Jung YS, Kim NH, Park JH, Park DI, Sohn CI. Correlation between hepatitis B virus infection and colorectal neoplasia. J Clin Med 2019; 8: 2085. doi: 10.3390/jcm8122085.
Liu T, Li W, Zhang Y, Siyin ST, Zhang KQ, Song M, et al. Associations between hepatitis B virus infection and risk of colorectal cancer: a population-based prospective study. BMC Cancer 2021; 21: 1119 (2021). https://doi.org/10.1186/s12885-021-08846-w.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Thailand's National Cancer Institute Foundation
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความทีตีพิมพ์ในวารสารโรคมะเร็งนี้ถือว่าเป็นลิขสิทธิ์ของมูลนิธิสถาบันมะเร็งแห่งชาติ และผลงานวิชาการหรือวิจัยของคณะผู้เขียน ไม่ใช่ความคิดเห็นของบรรณาธิการหรือผู้จัดทํา